WeVote
Log In

Bill

Bill

HB 2378

Therapeutically equivalent drug products; provisions for return of outdated drugs.

2025 Regular Session Introduced by Keith Hodges

Virginia law now allows pharmacists to substitute therapeutically equivalent drugs and accept returns of outdated medications, effective July 1, 2025.

Acts of Assembly Chapter text (CHAP0270)
0
WeVote Research Nonpartisan
Bill Summary · HB 2378

Legislative bill overview

HB 2378 allows pharmacists to dispense therapeutically equivalent drug products as substitutes for prescribed medications and establishes a process for returning outdated or unused drugs to pharmacies without penalty. The bill takes effect July 1, 2025, and modernizes Virginia's pharmacy regulations around drug substitution and waste management.

Why is this important

This legislation addresses two practical healthcare challenges: it enables pharmacists to make clinically appropriate generic or equivalent substitutions (potentially reducing costs), and it creates a legal mechanism for safe disposal of expired medications, reducing environmental contamination and accidental poisoning risks. The policy balances patient access to affordable medications with public health and safety.

Potential points of contention

  • Physician autonomy concerns: Some prescribers may object to automatic substitutions of their prescribed drugs without explicit prior authorization, though therapeutic equivalency suggests clinical interchangeability
  • Liability questions: The bill's language on return procedures may leave unclear who bears responsibility if returned drugs are mishandled or create liability issues for pharmacies accepting outdated medications
  • Implementation details: Specific protocols for drug return, storage, and destruction aren't detailed in the summary, potentially creating compliance ambiguity for pharmacies during the initial rollout

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.